Tokyo, Apr 21, 2006 (JCN) - Astellas Pharma announced on April 20 that it had obtained additional approval for Funguard for Infusion 50mg/75mg, its proprietary candin antifungal agents, and manufacturing approval for Vesicare Tablet, its proprietary agent for overactive bladder (OAB), from the Ministry of Health, Labor and Welfare.
